Curran Daniel J. 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Nov 24, 2025
Insider Transaction Report
Form 4
Curran Daniel J.
Director
Transactions
- Award
Restricted Stock Units
2025-11-20+5,468→ 63,583 total→ Common Stock (5,468 underlying) - Award
Options to purchase common stock
2025-11-20+18,115→ 58,115 totalExercise: $22.77Exp: 2032-11-20→ Common Stock (18,115 underlying)
Footnotes (3)
- [F1]Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027 and 1/3rd on November 20, 2028.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F3]Shares of common stock will be delivered to the Reporting Person upon vesting.